Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 27, 2025 | (Q2)Jun 28, 2025 | (Q1)Mar 29, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 28, 2024 | (Q2)Jun 29, 2024 | (Q1)Mar 30, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -46.95%2.68M | -96.01%868K | -128.01%-1.35M | 226.96%34.05M | -15.95%2.42M | 83.30%5.05M | 482.39%21.76M | 361.46%4.81M | -31.65%10.41M | -54.08%2.88M |
| Net income from continuing operations | 32.19%2.93M | -66.30%2.67M | -39.27%3.66M | -26.15%21.74M | -51.82%5.59M | -65.43%2.22M | 36.13%7.91M | 7.19%6.03M | -17.10%29.43M | -47.31%11.59M |
| Operating gains losses | ---- | 2.61%-2.94M | 69.86%-22K | 55.82%-10.45M | 20.41%-10.25M | 99.97%-1K | 18.32%-3.02M | 67.41%-73K | 31.18%-23.65M | 52.61%-12.87M |
| Depreciation and amortization | 297.12%552K | 353.91%581K | 131.37%236K | 42.42%517K | 46.53%148K | 31.13%139K | 54.22%128K | 39.73%102K | 32.97%363K | 27.85%101K |
| Deferred tax | -81.79%171K | -71.42%906K | -48.86%1.52M | -12.83%9.25M | -54.85%2.17M | -21.75%939K | 35.82%3.17M | 30.47%2.98M | -22.13%10.61M | -42.23%4.8M |
| Other non cashItems | -1,395.65%-1.19M | ---- | -343.96%-1.55M | 70,790.00%14.18M | --4.99M | --92K | --11.35M | 120.01%637K | --20K | ---- |
| Change In working capital | -95.00%117K | -91.68%334K | 35.09%-2.86M | 183.42%2.24M | 215.45%284K | 578.94%2.34M | 240.05%4.02M | -40.67%-4.4M | -199.52%-2.68M | -106.65%-246K |
| -Change in receivables | 108.14%232K | -121.22%-801K | 149.41%1.05M | 169.98%725K | -28.46%1.92M | 48.31%-2.85M | -0.92%3.78M | -5.16%-2.12M | -956.20%-1.04M | -48.90%2.68M |
| -Change in inventory | -607.69%-924K | 142.80%1.97M | 22.95%-1.1M | -197.47%-501K | 69.41%-67K | 149.06%182K | -72.94%813K | 24.79%-1.43M | 228.50%514K | 75.85%-219K |
| -Change in payables and accrued expense | -90.48%503K | 166.22%494K | -116.04%-2.68M | 184.53%1.55M | 38.66%-1.75M | 2.58%5.29M | 81.15%-746K | -574.46%-1.24M | -176.31%-1.84M | -174.37%-2.85M |
| -Change in other working capital | 210.47%306K | -866.09%-1.33M | -131.87%-123K | 242.02%463K | 28.57%180K | -214.94%-277K | 110.38%174K | -60.17%386K | -157.19%-326K | -64.65%140K |
| Tax refund paid | 115.24%103K | 62.28%-676K | -416.85%-2.33M | 6.88%-3.43M | 0.78%-507K | 15.50%-676K | 9.17%-1.79M | -14.18%-451K | -47.04%-3.68M | 20.65%-511K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -46.95%2.68M | -96.01%868K | -128.01%-1.35M | 226.96%34.05M | -15.95%2.42M | 83.30%5.05M | 482.39%21.76M | 361.46%4.81M | -31.65%10.41M | -54.08%2.88M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 55.67%-129K | 80.08%-95K | 3.85%-8.82M | -16,419.64%-9.14M | 1,350.00%800K | 0.68%-291K | -322.90%-477K | -4,708.54%-9.17M | 117.55%56K | 21.95%-64K |
| Net PPE purchase and sale | ---- | 80.08%-95K | ---- | 101.48%1.36M | ---- | ---- | -322.90%-477K | ---- | 1,044.07%675K | ---- |
| Net business purchase and sale | --0 | --0 | ---6.51M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net other investing changes | 55.67%-129K | ---- | 74.83%-2.31M | -1,596.12%-10.5M | 24.22%-560K | 0.68%-291K | ---- | -4,708.54%-9.17M | -63.76%-619K | ---739K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 55.67%-129K | 80.08%-95K | 3.85%-8.82M | -16,419.64%-9.14M | 1,350.00%800K | 0.68%-291K | -322.90%-477K | -4,708.54%-9.17M | 117.55%56K | 21.95%-64K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -7.03%-2.77M | 78.61%-2.76M | -106.92%-455K | 22.73%-11.49M | 30.09%-2.59M | 30.45%-2.59M | -246.05%-12.89M | 276.70%6.58M | 7.09%-14.87M | 0.51%-3.7M |
| Net issuance payments of debt | ---178K | 98.39%-166K | -79.27%2.14M | --0 | --0 | --0 | ---10.3M | --10.3M | --0 | --0 |
| Cash dividends paid | -0.15%-2.59M | -0.08%-2.59M | 30.43%-2.59M | 22.73%-11.49M | 30.09%-2.59M | 30.45%-2.59M | 30.48%-2.59M | -0.05%-3.72M | 7.09%-14.87M | 0.51%-3.7M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -7.03%-2.77M | 78.61%-2.76M | -106.92%-455K | 22.73%-11.49M | 30.09%-2.59M | 30.45%-2.59M | -246.05%-12.89M | 276.70%6.58M | 7.09%-14.87M | 0.51%-3.7M |
| Net cash flow | ||||||||||
| Beginning cash position | -78.74%2.65M | 14.35%4.63M | 732.88%15.25M | -70.61%1.83M | 437.66%14.62M | 212.92%12.45M | 7.92%4.05M | -70.61%1.83M | -14.84%6.23M | -27.80%2.72M |
| Current changes in cash | -110.13%-220K | -123.62%-1.98M | -579.07%-10.62M | 405.05%13.42M | 171.06%631K | 272.44%2.17M | 3,600.44%8.4M | 189.43%2.22M | -305.06%-4.4M | -136.04%-888K |
| End cash Position | -83.41%2.43M | -78.75%2.65M | 14.35%4.63M | 732.88%15.25M | 732.88%15.25M | 437.66%14.62M | 212.92%12.45M | 7.92%4.05M | -70.61%1.83M | -70.61%1.83M |
| Free cash from | -46.95%2.68M | -97.12%610K | -128.01%-1.35M | 226.96%34.05M | -15.95%2.42M | 83.30%5.05M | 488.94%21.15M | 361.46%4.81M | -31.65%10.41M | -55.85%2.88M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.